Participant Demographics and Baseline Characteristics
cough, fever
RESPIRATORY SYSTEM DISEASE
In total, from 20 September 2020 to 31 September 2021, 1512 participants were enrolled and randomized to either the intervention (n = 761) or control (n = 751) arm from 2 main recruiting health centers as shown in Patient Baseline Demographics and CharacteristicsThe median age of participants was 2 years (1–4). The most common clinical presentations were fever in 1428 of 1512 (94.4%) and/or cough in 968 of 1512 (64.0%). Typically, participants experienced symptoms for <4 days upon enrollment in the study. The mean duration (standard deviation) for fever was 2.9 (3.0) and 2.8 (1.6) days and 3.9 (3.0) and 3.6 (2.7) days for cough in the intervention and control arms, respectively. Most participants (846 of 1512, 74%) had a presumptive diagnosis of a respiratory system disease, and this was consistent at both Shai-Osudoku District Hospital and St. Andrew's Catholic Hospital. After testing, 1110 of 1512 participants (73.4%) were deemed by clinicians to have a respiratory diagnosis (